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Relation of exercise-induced left ventricular (LV) outflow tract obstruction to functional capacity in hypertrophic cardiomyopathy (HC)  is incompletely defined. Thus we aimed at assessing patterns of onset of physiologically provoked LV outflow gradients and exercise performance in patients 74 consecutive HC patients (age 45±16 years; 74% male) without LV outflow obstruction at rest in whom subaortic gradients were measured serially with echocardiography during maximal, symptom-limited upright bicycle exercise testing. Time-course of provoked gradients and the relation to exercise performance were assessed. Of the 74 patients, 30 (41%) developed dynamic LV outflow gradients ≥30 mm Hg during upright exercise (mean 78±37mmHg) which correlated highly with those gradients measured supine in the immediate recovery period (R2=0.97). The 16 patients in whom outflow obstruction developed rapidly at low exercise levels (≤5 metabolic equivalents [METs]) achieved significantly reduced exercise capacity (6.1±1.3 vs. 8.0±1.6 METs; p<0.01) when compared to the other 14 patients in whom obstruction appeared later at higher exercise levels of >5 METs. Timing of gradient onset was not predictable based on baseline clinical and echocardiographic features, peak exercise LV outflow tract gradients, or symptoms. In conclusion, in HC patients without outflow obstruction at rest, earlier onset of LV outflow tract gradients during physiologic exercise was associated with impaired exercise performance. These findings provide insights into the determinants of functional impairment in HC and support the potential value of exercise echocardiography in the clinical assessment of patients with this disease.
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	Left ventricular (LV) outflow obstruction under resting conditions represents an important determinant of outcome in patients with hypertrophic cardiomyopathy (HC) (1,2). Furthermore, a significant proportion of HC patients without obstruction at rest may develop substantial outflow gradients while engaged in physical exertion (3,4).The clinical significance of physiologically provocable outflow obstruction is unresolved (5,6). Previous studies on inducible, labile obstruction in HC have focused largely on single measurements often obtained at peak or immediately after exercise, the latter generally measured in the supine position (3,4). However, we have considered here the possibility that the activity level at which dynamic gradients are generated during exertion may impact exercise capacity. Therefore, in the present study, we have revisited the issue of physiologically-induced outflow gradients in HC with serial measurements made during symptom-limited upright bicycle exercise testing, to determine whether the timing of gradient onset during exercise is of clinical relevance in HC patients.
METHODS
	The study group comprised 74 HC patients without LV outflow tract obstruction at rest (basal outflow gradient <30 mm Hg), consecutively studied at our institution with exercise echocardiography (Table). Mean age was 45±16 years; 53 (72%) were male. Historically, most patients (n=70, 95%) had no or only mild exertional symptoms (Table). Clinical diagnosis of HC was based on the demonstration by 2-dimensional echocardiography of a hypertrophied and nondilated  left ventricle (wall thickness ≥15 mm) in the absence of another cardiac or systemic disease capable of producing a similar degree of hypertrophy (5-7).
	Patients had cardioactive medications withdrawn at least 5 half-lives prior to the exercise test and each fasted >4 hours before the test. Maximum, symptom-limited exercise tests were performed on a bicycle ergometer in the upright position. Exercise began at an initial workload of 25 watts (W), with stepwise 25W increments every 2 minutes. A 12-lead ECG was monitored continuously and recorded at baseline and at each minute during exercise as well as post-exercise. Arterial blood pressure was measured using a mercury sphygmomanometer at baseline and every 2 minutes during exercise and the post-exercise phase. Patients were encouraged to perform maximally to achieve their expected heart rate. Maximum predicted heart rate was calculated as 220-age, and percent of predicated heart rate was calculated as (maximum heart rate attained/maximum predicated heart rate) x 100. Exercise was terminated when the predicted heart rate was achieved or when fatigue, dyspnea, chest pain or hypotension intervened. 
Peak exercise was defined as maximal attained workload before discontinuation. Peak functional capacity was estimated as metabolic equivalents (METs), one MET being defined as the energy expended at rest, equivalent to an oxygen consumption of 3.5 ml per kg of body weight per minute, as recommended (8). No adverse events or clinically relevant arrhythmias occurred during exercise testing. 
	 Standard echocardiographic studies were performed in the left lateral supine decubitus with commercially available instruments according to current guidelines. Magnitude and distribution of LV hypertrophy was assessed, as previously described (9-11). Subaortic obstruction was defined as mechanical impedance to outflow due to systolic anterior motion (SAM) with mitral valve-ventricular septal contact in mid-systole (7,12,13), and graded semi-quantitatively, as previously described (14). Peak instantaneous LV outflow tract gradients were measured at rest (and with Valsalva maneuver) in the left lateral position with continuous-wave Doppler interrogation in the apical 5-chamber view, taking care to avoid contamination of the waveform by the mitral regurgitation jet (1,3). Mitral regurgitation was graded as none or trivial (0), mild (1+), moderate (2+), severe (3+).
	 Echocardiography was performed with patients sitting upright on the bicycle ergometer under basal conditions and serially every 2 minutes during exercise at each 25W workload, with 9±3 measurements/patient (range 4-12). LV was imaged in the apical and parasternal long-axis views in order to identify and grade SAM and mitral regurgitation, and estimate LV outflow tract gradient with continuous-wave Doppler. Following termination of exercise, patients were immediately placed in the left lateral decubitus position and LV outflow tract velocities were measured again in the apical view by continuous-wave Doppler. 
	For the purpose of the present study exercise-induced gradients were considered clinically relevant when ≥30 mm Hg. Onset of outflow obstruction during exercise was regarded as early when occurring at a workload of ≤ 5 METs and late at a workload of > 5 METs (8).
	Data were expressed as mean ± SD. Paired student’s t-test or one-way analysis of variance were used to compare normally distributed data. Chi-square test (and where applicable, Yate’s corrected chi-square test) compared noncontinuous variables expressed as proportions. Predictors of marked exercise-inducing obstruction were assessed by multivariate logistic regresison analysis. P values < 0.05 were considered significant. Calculations were performed using SPSS 12.0 (SPSS Inc., Chicago, Ill).

RESULTS
	Data were obtained in the 74 HC patients with LV outflow gradients <30 mm Hg at rest supine and erect on cycle ergometer (Table). Twenty-four patients (32%) attained >85% of maximal predicated heart rate, while the remaining 50 (68%) achieved sub-maximal target heart rates, and terminated the test due to fatigue (n= 40), dyspnea (n=26) or in the presence of systolic BP fall >25 mmHg during exercise (n=4).
	Of the 74 study patients, 30 (40%) developed dynamic LV outflow tract gradients ≥30 mmHg during exercise due to SAM and mitral-septal contact (Figure 1). The remaining 44 patients (60%) remained below the 30 mmHg gradient threshold.
	LV outflow tract gradients measured upright at peak exercise were slightly lower than those obtained supine immediately after exercise (39±35 mm Hg vs. 44±40 mmHg, respectively; p<0.01). Nevertheless, correlation between the 2 measurements was high (R2=0.974), with small absolute individual differences (average 5±7 mmHg) (Figure 2). 
In the 30 patients with provoked obstruction, gradients were 70±30 mm Hg at peak exercise and 79±36 mm Hg immediately post-exercise (p<0.01), with absolute individual differences averaging 10±8 mm Hg (range 0 to 33) (Figure 3). These gradients were reached during exercise at 4.6±1.7 METs (range 2.1-6.9). In 29 of the 30 patients, gradients exceeded ≥30 mm Hg both at peak exercise and in recovery; the exception was a 65-year old woman with a peak gradient of 28 mmHg upright and 33 mmHg supine. In addition, each of the 22 patients achieving gradients ≥50 mmHg in the supine position, exceeded the same threshold in the upright measurements (Figure 3).
	Two patterns of LV outflow tract gradient onset were identified according to predetermined criteria (figure 4): early obstruction, (development of ≥30 mm Hg gradients at <5 METs), observed in 16 patients, and late obstruction (at >5 METs), in the remaining 14 patients (Table 1). Compared to patients with late obstruction, patients with early obstruction reduced exercise capacity (6.1±1.3 METs vs. 8.0±1.6 METs, p<0.01). This finding was not predictable based on baseline clinical and echocardiographic features, peak exercise LV outflow tract gradients, % predicted maximal heart rate, severity of mitral regurgitation at peak exercise and NYHA functional class (Table 1).
	Compared to patients without provoked gradients ≥30 mm Hg, those with provokable gradients were more often male (87% vs. 61%, p=0.02), had larger left atrial size (45±7 mm vs. 41±7 mm, p=0.045), as well as higher LV outflow tract velocities at rest (1.8±0.5 m/sec vs. 1.4±0.3 m/sec, p=0.002). At multivariate logistic regression analysis, independent predictors of exercise-induced obstruction were male gender (hazard ratio 4.0, 95% confidence interval [CI] 1.1-14.4, p = 0.036), higher resting LV outflow tract velocity (hazard ratio 1.23 for each 0.1 m/s increase; 95% CI 1.07-1.42; p=0.0043) and lower resting diastolic blood pressure (hazard ratio 0.93 for each mmHg increase; 95% CI 0.89-0.99; p=0.027).
DISCUSSION
	To achieve an enhanced understanding of the pathophysiology of exercise-induced LV outflow obstruction in HC, we devised the present study protocol based on serial gradient assessment at each step of a symptom-limited upright bicycle exercise test. Indeed, we found that this strategy provided important information not available with a single gradient measurement at peak exercise or in the immediate recovery period. With real-time monitoring of LV outflow tract velocities during physiologic exercise, we were able to show that the timing of onset of obstruction dictated the degree to which exercise capacity was impaired in HC patients with provokable gradients.
	Of 30 patients who developed LV outflow obstruction ≥30 mmHg with exercise, about 50% did so early at low workloads (<5 METs), suggesting that substantial impedance to outflow may be produced even during routine daily activities, and impose an hemodynamic burden on LV function (15). The other half, however, achieved the same degree of obstruction with moderate-to-high workloads, equivalent to higher intensity of physical activity such as may be attained in sports or manual work. Notably, these differences in the timing of provoked obstruction had a direct impact on the exercise performance exhibited by our patients. Despite similar baseline clinical and echocardiographic features, and physiologically provoked gradients of similar magnitude, individuals with early development of outflow obstruction during exercise performed at a lower level than those who developed obstruction later during exercise. Specifically, those patients with early gradients achieved an average of 6.1 METs at peak exercise, representing absolute impairment in functional capacity (8,16), as compared to an average of 8.0 METs  in patients with late obstruction. Of note, such differences place the two HC subsets in substantially different risk categories for all-cause and cardiovascular mortality, based on evidence from non-HC patients as well as the general population (17-19). For example, in the recent study of Kokkinos et al. (20), demonstrating a strong inverse association between exercise capacity and all-cause mortality in >4,000 pre-hypertensive individuals, the ≤6 METs threshold identified subjects at low fitness level and increased risk (20). By extrapolation, it is possible that the reduction in exercise performance we observed associated with early development of outflow obstruction may prove of long-term disease progression in HC patients. The present analysis, cross-sectional in study design and largely based on patients with no or only mild symptoms, does not allow us to draw firm conclusions in this regard. Due to the characteristic slow progression of the HC disease process, extended follow-up periods in larger groups of patients will be necessary to achieve sufficient statistical power and examine the significance of provocable outflow gradient on heart failure progression and outcome.
	Our findings might have potential implications for patient management, supporting the view that assessment of LV outflow gradients during exercise, generally not performed in clinical practice, should be selectively considered in HC patients. For those individuals capable of physiologically provoking outflow obstruction, the level of recommended of either working or leisure-time physical activity can be tailored to the results of the exercise test, by advising patients to maintain a maximum heart rate below the level at which the gradient was initially generated. The finding that different thresholds exist for generation of intraventricular gradients in HC with inducible obstruction raises the consideration for potential treatment strategies including pharmacological interventions which should be specifically addressed in future studies (21,22). Moreover, serial exercise echocardiography could be subsequently proposed for longitudinal assessment of the efficacy of such pharmacologic therapy on gradient generation capacity and exercise tolerance (22).
	Finally, we found substantial agreement between the magnitude of outflow gradients measured at the final step of the exercise test in the upright position and those gradients obtained in the supine position immediately following cessation of exercise. Specifically, all but one of the 30 patients with gradients ≥30 mmHg, and all those ≥50 mmHg, in the supine position also exceeded the same thresholds in upright measurements. Observed individual discrepancies were relatively minor, with post-exercise supine gradients overestimating somewhat the upright gradients on the average of 5 mmHg for the study group. These differences could be related to reduction in LV outflow tract area by the combination of sudden reduction in venous return during recovery, coupled with a persistently low peripheral resistance and continued sympathetic drive (4,23,24). Moreover, there are potential technical factors in play, including recognition that alignment of the ultrasound cursor in the LV outflow tract may be more reliable after cessation of exercise with reduced chest movement.  
	Our findings differ from 2 other studies (25,26) suggesting a substantial underestimation of gradients assessed supine in the recovery period of treadmill exercise testing compared with those detected upright. However, such patients were assessed while on active treatment with beta-blockers, verapamil or both, which could have substantially blunted the magnitude and altered the time-course of inducible obstruction. Such heterogeneous results may also underscore the extremely dynamic degree of LV outflow obstruction that can be observed in individual patients (27). Nevertheless, our findings, obtained during physiological exercise and in pharmacological wash-out, show that it is equally acceptable to use either the upright or post-exercise supine technique to assess the magnitude of inducible obstruction in HC for clinical purposes (3). 
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LEGENDS
Figure 1.	Exercise-induced obstruction in HCs. A., B., C. Obtained at rest. A. Apical 5-chamber long-axis view at end-systole with only mild SAM (arrow-head); B. continuous-wave Doppler showing normal LV outflow tract velocity (1.8 m/sec); C. SAM-related posteriorly-directed mild mitral regurgitation jet. In D., E., F. Obtained at peak exercise in identical view; D. SAM with septal contact (arrow); E. corresponding continuous-wave Doppler velocity of 5 m/sec (i.e., 100 mmHg gradient); F. substantial increase in magnitude of mitral regurgitation. SAM=systolic anterior motion of the mitral valve.
Figure 2.	Comparison of upright versus supine provokable LV outflow gradients. Scatterplot of gradients measured at peak exercise in the upright position (ordinate), and post-exercise in the supine position (abscissa), showing excellent correlation between the two measurements. LVOT=left ventricular outflow tract.
Figure 3.	Individual gradient variations in HC patients with provokable obstruction. Changes in LV outflow tract gradient from rest (basal) conditions to peak upright exercise in supine position immediately after exercise. Shown for 30 HC patients with inducible gradients ≥30 mmHg. Each line connects the 3 intervals of the test for individual patients. At baseline LV outflow gradient was considered to be zero, as systolic anterior motion of the mitral valve was mild or absent, which excluded mechanical impedance to flow.  
 Figure 4.	Patterns of gradient provocation with exercise. In a 45-year-old patient with early obstruction (solid line and square symbols); a 55 mmHg inducible gradient was measured at 50 watts (4.2 METs), and exercise was terminated at 100 watts (5.8 METs) due to dyspnea associated with a peak upright gradient of 70 mm Hg; peak post-exercise supine gradient was 87 mmHg. In a 47-year-old patient with late obstruction (broken line and triangles); a 52 mmHg gradient was induced at 100 watts (5.8 METs), and exercise was terminated at 125 watts (78.5 METs) due to fatigue, when the gradient had increased to 65 mmHg; peak post-exercise supine gradient was 85 mmHg.












